Rob C Holmes
CIK 1845093 · View on SEC EDGAR ↗
First SEC filing: May 18, 2021 · Latest: June 8, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 5, 2026 | TCBIO | S | 49,100 | $101.88 | $5,002,308 | 167,635 | — | — | -79.8% (price as of 2026-08-19) |
| Sept. 3, 2021 | TCBIO | P | 8,308 | $60.29 | $500,889 | 265,029 Direct | +3.24% | Acquired | -65.9% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 14, 2025 | TCBIO | 2024 Restricted Stock Units | Common Stock | $0.00 | — | 9,565 | Disposed |
| Feb. 7, 2025 | TCBIO | Restricted Stock Units | Common Stock (8,708) | $0.00 | — | 8,708 | Disposed |
| Feb. 7, 2025 | TCBIO | Restricted Stock Units | Common Stock (8,221) | $0.00 | — | 8,221 | Disposed |
| Feb. 7, 2025 | TCBIO | 2022 Performance Stock Units | Common Stock | $0.00 | March 15, 2025 | 42,519 | Disposed |
| Jan. 28, 2025 | TCBIO | 2025 Restricted Stock Units | Common Stock (665) | $0.00 | — | 665 | Disposed |
| Jan. 28, 2025 | TCBIO | 2025 Restricted Stock Units | Common Stock (28,267) | $0.00 | — | 28,267 | Acquired |
| July 29, 2024 | TCBIO | 2024 Restricted Stock Units | Common Stock (61,491) | $0.00 | — | 61,491 | Acquired |
| Feb. 26, 2024 | TCBIO | 2021 Performance Stock Units | Common Stock | $0.00 | March 15, 2024 | 19,714 | Disposed |
| Feb. 26, 2024 | TCBIO | Restricted Stock Units | Common Stock (22,426) | $0.00 | — | 22,426 | Disposed |
| Feb. 16, 2024 | TCBIO | 2024 Restricted Stock Units | Common Stock | $0.00 | — | 29,388 | Acquired |
| Feb. 16, 2024 | TCBIO | 2024 Restricted Stock Units | Common Stock (691) | $0.00 | — | 691 | Disposed |
| Feb. 16, 2024 | TCBIO | 2024 Restricted Stock Units | Common Stock (58,775) | $0.00 | — | 58,775 | Acquired |
| Feb. 9, 2024 | TCBIO | Restricted Stock Units | Common Stock (8,094) | $0.00 | — | 8,094 | Disposed |
| Feb. 8, 2024 | TCBIO | Restricted Stock Units | Common Stock (7,834) | $0.00 | — | 7,834 | Disposed |
| Feb. 1, 2024 | TCBIO | Restricted Stock Units | Common Stock (228,261) | $0.00 | — | 228,261 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 18, 2021 | DDT | Common Class A | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $937,500 | $2,500,000 | $17,179,310 | — | — | — | $6,150 | $23,622,960 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.